Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide

AIMS/INTRODUCTION: To investigate the efficacy and safety of vildagliptin, a potent dipeptidyl peptidase‐4 inhibitor, as add‐on to nateglinide, compared with switching to vildagliptin in Japanese type 2 diabetes patients poorly controlled with nateglinide. MATERIALS AND METHODS: A total of 40 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo‐Fujimaki, Kyoko, Hirose, Takahisa, Yoshihara, Tomoaki, Sato, Fumihiko, Someya, Yuki, Ohmura, Chie, Kanazawa, Akio, Fujitani, Yoshio, Watada, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210064/
https://www.ncbi.nlm.nih.gov/pubmed/25411599
http://dx.doi.org/10.1111/jdi.12160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210064/
https://www.ncbi.nlm.nih.gov/pubmed/25411599
http://dx.doi.org/10.1111/jdi.12160

Ejemplares similares